Cargando…
Correction: Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial
Autores principales: | Murphy, Nicholas, Tamman, Amanda J. F., Lijffijt, Marijn, Amarneh, Dania, Iqbal, Sidra, Swann, Alan, Averill, Lynnette A., O’Brien, Brittany, Mathew, Sanjay J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517107/ https://www.ncbi.nlm.nih.gov/pubmed/37349477 http://dx.doi.org/10.1038/s41386-023-01618-z |
Ejemplares similares
-
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial
por: Murphy, Nicholas, et al.
Publicado: (2023) -
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression
por: O'Brien, Brittany, et al.
Publicado: (2019) -
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
por: O’Brien, Brittany, et al.
Publicado: (2019) -
Does mismatch negativity have utility for NMDA receptor drug development in depression?
por: Murphy, Nicholas, et al.
Publicado: (2021) -
A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD
por: Lijffijt, Marijn, et al.
Publicado: (2019)